| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9225557 | Journal of Allergy and Clinical Immunology | 2005 | 10 Pages |
Abstract
Response to fluticasone and montelukast vary considerably. Children with low pulmonary function or high levels of markers associated with allergic inflammation should receive ICS therapy. Other children could receive either ICSs or LTRAs.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Stanley J. MD, Brenda R. MS, Fernando D. MD, Vernon M. PhD, Robert F. MD, Robert C. MD, Robert S. MD, PhD, Gary MD, Joseph D. MD, Leonard B. MD, Gordon R. MD, Theresa W. MD, Gregory MD, Wayne J. MD, Mark H. MD, Christine A. PharmD, Lynn M. MD,